05/09/2024
6:37 AM | Sensei Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
3:35 PM | Sensei Biotherapeutics (Filer)
| Form DEFA14A | |
04/29/2024
3:40 PM | Sensei Biotherapeutics (Filer)
| Form ARS | |
04/12/2024
3:31 PM | Sensei Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
6:45 AM | Sensei Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
5:00 PM | Newtyn Management, LLC (Filed by)
Sensei Biotherapeutics (Subject)
| Form SC 13D/A | |
02/29/2024
3:44 PM | Sensei Biotherapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
|
02/28/2024
6:31 AM | Sensei Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
5:25 PM | Colgan Erin (Reporting)
Sensei Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
5:28 PM | Celebi John (Reporting)
Sensei Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
5:37 PM | Sensei Biotherapeutics (Issuer)
van der Horst Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
4:34 PM | Newtyn Management, LLC (Filed by)
Sensei Biotherapeutics (Subject)
| Form SC 13D/A | |
01/04/2024
7:14 AM | Sensei Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
3:40 PM | Sensei Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
6:35 AM | Sensei Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
5:07 AM | Sensei Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
3:50 PM | Krebs Stephanie (Reporting)
Sensei Biotherapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
3:53 PM | Krebs Stephanie (Reporting)
Sensei Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/20/2023
4:01 PM | Sensei Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2023
7:43 AM | Celebi John (Reporting)
Sensei Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
4:31 PM | Colgan Erin (Reporting)
Sensei Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
4:33 PM | Celebi John (Reporting)
Sensei Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
4:33 PM | Sensei Biotherapeutics (Issuer)
van der Horst Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
4:34 PM | Gallagher Patrick Stephen (Reporting)
Sensei Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
4:15 PM | Sensei Biotherapeutics (Filer)
| Form 424B5 | |
08/04/2023
3:41 PM | Cambrian BioPharma Inc (Filed by)
Sensei Biotherapeutics (Subject)
| Form SC 13G/A | |
08/03/2023
3:32 PM | Sensei Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023
7:45 AM | Sensei Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2023
4:00 PM | Broder Samuel (Reporting)
Sensei Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
4:02 PM | RICKS THOMAS G (Reporting)
Sensei Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
4:03 PM | RINGO WILLIAM R (Reporting)
Sensei Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
3:44 PM | Holmen Bob (Reporting)
Sensei Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
3:46 PM | Sensei Biotherapeutics (Issuer)
Vojta Deneen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
3:48 PM | English Jessie (Reporting)
Sensei Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
3:50 PM | Humer Kristian (Reporting)
Sensei Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2023
3:31 PM | Sensei Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2023
8:00 AM | Sensei Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
3:30 PM | Sensei Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2023
3:41 PM | Sensei Biotherapeutics (Filer)
| Form ARS | |
06/15/2023
3:31 PM | Sensei Biotherapeutics (Filer)
| Form DEF 14A | |
05/23/2023
3:50 PM | Apeiron Investment Group Ltd. (Filed by)
Sensei Biotherapeutics (Subject)
| Form SC 13D/A | |
Amazon's betting big on this unknown AI company (Ad) Amazon's Betting Big on This Unknown AI Company
Amazon has just made a stunning $144 million investment in one small AI company. Discover why this company |
05/23/2023
3:30 PM | Sensei Biotherapeutics (Filer)
| Form DEFA14A | |
